Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 7,781 - 7,800 results of 7,930 for search '(( via ((mean decrease) OR (linear decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 0.52s Refine Results
  1. 7781

    Table_3_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.xlsx by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  2. 7782

    DataSheet_9_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  3. 7783

    Table_6_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.xlsx by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  4. 7784

    DataSheet_4_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  5. 7785

    Table_5_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.xlsx by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  6. 7786

    Table_4_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.xlsx by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  7. 7787

    Effects of Meloxicam on the Welfare of Holstein Calves from 6 Weeks to 6 Months Old Undergoing Amputation Dehorning by Jiancheng Qi (17878619)

    Published 2024
    “…<p dir="ltr"><a href="" target="_blank">Amputation </a>dehorning (AD) is a common practice performed on calves, causing harmful effects such as pain, distress, anxiety, fear. …”
  8. 7788

    Image_1_Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats.tiff by Yan-Ting Shiu (9157814)

    Published 2021
    “…Natural Vascular Scaffolding (NVS) Therapy is a new technology that interlinks collagen and elastin via photoactivation of a locally delivered small molecule (4-amino-1,8-naphtalamide). …”
  9. 7789

    Image_2_Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats.tiff by Yan-Ting Shiu (9157814)

    Published 2021
    “…Natural Vascular Scaffolding (NVS) Therapy is a new technology that interlinks collagen and elastin via photoactivation of a locally delivered small molecule (4-amino-1,8-naphtalamide). …”
  10. 7790

    Data_Sheet_1_Asthma prevalence based on the Baidu index and China's Health Statistical Yearbook from 2011 to 2020 in China.xlsx by Yahui Li (315104)

    Published 2023
    “…Although China has made early efforts in asthma epidemiology and prevention, there is still a lack of unified and comprehensive epidemiological research within the country. …”
  11. 7791

    Image_3_Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats.tiff by Yan-Ting Shiu (9157814)

    Published 2021
    “…Natural Vascular Scaffolding (NVS) Therapy is a new technology that interlinks collagen and elastin via photoactivation of a locally delivered small molecule (4-amino-1,8-naphtalamide). …”
  12. 7792

    DataSheet1_Case Report: Chemotherapy-free treatment with camrelizumab and anlotinib for elderly patients with KRAS and TP53 mutated advanced lung cancer.docx by Wenbo Qi (8863361)

    Published 2023
    “…Anlotinib 12 mg was administered orally daily before breakfast for 2 weeks with a week of rest in every cycle of 21 days. A reduction in alpha-fetoprotein, carcinoembryonic antigen, CA125, CA199, and CA724 levels was observed up to the first cycle, which decreased within the normal limits up to the second cycle and continued until the eighteenth cycle. …”
  13. 7793

    Image1_Case Report: Chemotherapy-free treatment with camrelizumab and anlotinib for elderly patients with KRAS and TP53 mutated advanced lung cancer.TIF by Wenbo Qi (8863361)

    Published 2023
    “…Anlotinib 12 mg was administered orally daily before breakfast for 2 weeks with a week of rest in every cycle of 21 days. A reduction in alpha-fetoprotein, carcinoembryonic antigen, CA125, CA199, and CA724 levels was observed up to the first cycle, which decreased within the normal limits up to the second cycle and continued until the eighteenth cycle. …”
  14. 7794

    Fig 4 - by Adam Lampert (413952)

    Published 2024
    “…The ACT* is also higher when <i>α</i> is larger. The sub-panels demonstrate the shape of the optimal treatment profile, <i>A</i><sup>opt</sup>, and the population density, <i>n</i><sup>opt</sup>, as a function of the location, <i>x</i>. …”
  15. 7795

    Gosselin_SCIREP_Data by Romain Gosselin (9753734)

    Published 2021
    “…Filters and exclusion criteria are given in Table 1. Using a pseudo-random sequence of 20 numbers between 1 and 259 generated using GraphPad QuickCalc (<a href="https://www.graphpad.com/quickcalcs/randMenu">https://www.graphpad.com/quickcalcs/randMenu</a>), a final shortlist of 20 journals among the 259 preselected ordered by decreasing 2018 Impact Factor were selected (the latest available impact factor at the time of designing this study). …”
  16. 7796

    Parameter fitting for input and sampler layers in the EVA model. by Quynh-Anh Nguyen (847240)

    Published 2020
    “…They decreased exponentially and stabilized within a few seconds. …”
  17. 7797
  18. 7798

    Image_1_Prognostic Value of Right Ventricular Ejection Fraction Assessed by 3D Echocardiography in COVID-19 Patients.TIF by Yanting Zhang (338754)

    Published 2021
    “…</p><p>Conclusion: 3D-RVEF was the most robust independent predictor of mortality in COVID-19 patients and provided a higher predictive value over conventional RV function parameters and RVFWLS, which may be helpful to identify COVID-19 patients at a higher risk of death.…”
  19. 7799

    Presentation_1_Prognostic Value of Right Ventricular Ejection Fraction Assessed by 3D Echocardiography in COVID-19 Patients.pdf by Yanting Zhang (338754)

    Published 2021
    “…</p><p>Conclusion: 3D-RVEF was the most robust independent predictor of mortality in COVID-19 patients and provided a higher predictive value over conventional RV function parameters and RVFWLS, which may be helpful to identify COVID-19 patients at a higher risk of death.…”
  20. 7800

    Supplementary information files for "Longitudinal performance changes in transgender women athletes pre and post gender affirming hormone therapy" by Joanna Harper (7357499)

    Published 2025
    “…</li><li>Nine TW runners had decreases in performance of approximately 15% with > 1 year of GAHT whereas 1 TW swimmer had decreases in performance of approximately 5%.…”